Medtronic will pay $51 million to settle federal complaints over ev3 marketing

The deal settles claims by U.S. prosecutors that ev3 (now part of Medtronic) improperly marketed a medical device for unapproved uses.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.